A dose-escalation study of gemcitabine (Gem) plus oxaliplatin (Ox) in combination with imatinib in patients (pts) with gemcitabine-refractory advanced pancreatic adenocarcinoma (PC). Background: Free ...
A Q&A with Michael Foote, MD, MSK Gastrointestinal Medical Oncologist and member of the Peritoneal Surface Malignancies Consortium Group The Peritoneal Surface Malignancies Consortium Group (PSM ...
New study and promising results from the first clinical trial in patients provide novel insights and new hope for one of the deadliest of cancers. Gastric cancer remains a formidable adversary, ...
Pseudomyxoma peritonei (PMP) is a clinicopathologic syndrome that is characterized by mucinous ascites and pools of mucin, including neoplastic, mucinous epithelium within the peritoneal cavity. 1 PMP ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback